Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-22-000159
Filing Date
2022-01-04
Accepted
2022-01-04 21:05:30
Documents
1
Period of Report
2022-01-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 9609
  Complete submission text file 0001562180-22-000159.txt   11140
Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Issuer) CIK: 0001590877 (see all company filings)

EIN.: 471851754 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O REGENXBIO INC. 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address
PAKOLA STEVE (Reporting) CIK: 0001700659 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37553 | Film No.: 22508607